2021 中国台湾指南建议:慢性阻塞性肺疾病的治疗(更新版)

2021-06-28 中国呼吸科专家组(统称) J Formos Med Assoc.2021 Jun 28;

慢性阻塞性肺疾病(COPD)在全世界范围内的发病率和死亡率都占有重要地位,早期疾病症状不易区分,导致诊断和干预率较低,近期,中国台湾COPD的治疗指南更新,主要内容涉及COPD的诊断、评估、监测以及管

中文标题:

2021 中国台湾指南建议:慢性阻塞性肺疾病的治疗(更新版)

英文标题:

Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations

发布日期:

2021-06-28

简要介绍:

慢性阻塞性肺疾病(COPD)在全世界范围内的发病率和死亡率都占有重要地位,早期疾病症状不易区分,导致诊断和干预率较低,近期,中国台湾COPD的治疗指南更新,主要内容涉及COPD的诊断、评估、监测以及管理等。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 中国台湾指南建议:COPD的治疗(更新版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=d95001c00213ea39, title=2021 中国台湾指南建议:慢性阻塞性肺疾病的治疗(更新版), enTitle=Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations, guiderFrom=J Formos Med Assoc.2021 Jun 28;, authorId=0, author=, summary=慢性阻塞性肺疾病(COPD)在全世界范围内的发病率和死亡率都占有重要地位,早期疾病症状不易区分,导致诊断和干预率较低,近期,中国台湾COPD的治疗指南更新,主要内容涉及COPD的诊断、评估、监测以及管, cover=https://img.medsci.cn/2021725/1627228284068_2020535.jpg, journalId=0, articlesId=null, associationId=745, associationName=中国呼吸科专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Jun 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>慢性阻塞性肺疾病(COPD)在全世界范围内的发病率和死亡率都占有重要地位,早期疾病症状不易区分,导致诊断和干预率较低,近期,中国台湾COPD的治疗指南更新,主要内容涉及COPD的诊断、评估、监测以及管理等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=295, tagName=COPD)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=295, guiderKeyword=COPD, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4830, appHits=162, showAppHits=0, pcHits=423, showPcHits=4665, likes=1, shares=17, comments=10, approvalStatus=1, publishedTime=Mon Jul 26 00:50:28 CST 2021, publishedTimeString=2021-06-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 25 23:51:31 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 17:17:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 中国台湾指南建议:COPD的治疗(更新版).pdf)])
2021 中国台湾指南建议:COPD的治疗(更新版).pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2106054, encodeId=927221060540c, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db822206100, createdName=double⭕, createdTime=Wed Dec 14 19:55:01 CST 2022, time=2022-12-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247437, encodeId=4640124e437ad, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d85710310, createdName=ms2000000623101699, createdTime=Tue Sep 06 11:00:11 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052999, encodeId=c4831052999be, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Sep 19 11:43:08 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013032, encodeId=2743101303270, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 23:43:18 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009200, encodeId=77ba10092007f, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Wed Aug 18 18:15:42 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2022-12-14 double⭕ 来自浙江省

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2106054, encodeId=927221060540c, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db822206100, createdName=double⭕, createdTime=Wed Dec 14 19:55:01 CST 2022, time=2022-12-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247437, encodeId=4640124e437ad, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d85710310, createdName=ms2000000623101699, createdTime=Tue Sep 06 11:00:11 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052999, encodeId=c4831052999be, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Sep 19 11:43:08 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013032, encodeId=2743101303270, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 23:43:18 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009200, encodeId=77ba10092007f, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Wed Aug 18 18:15:42 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2022-09-06 ms2000000623101699

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2106054, encodeId=927221060540c, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db822206100, createdName=double⭕, createdTime=Wed Dec 14 19:55:01 CST 2022, time=2022-12-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247437, encodeId=4640124e437ad, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d85710310, createdName=ms2000000623101699, createdTime=Tue Sep 06 11:00:11 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052999, encodeId=c4831052999be, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Sep 19 11:43:08 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013032, encodeId=2743101303270, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 23:43:18 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009200, encodeId=77ba10092007f, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Wed Aug 18 18:15:42 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-09-19 annie5685

    非常好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2106054, encodeId=927221060540c, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db822206100, createdName=double⭕, createdTime=Wed Dec 14 19:55:01 CST 2022, time=2022-12-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247437, encodeId=4640124e437ad, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d85710310, createdName=ms2000000623101699, createdTime=Tue Sep 06 11:00:11 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052999, encodeId=c4831052999be, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Sep 19 11:43:08 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013032, encodeId=2743101303270, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 23:43:18 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009200, encodeId=77ba10092007f, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Wed Aug 18 18:15:42 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-08-30 ms3000001491842979

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2106054, encodeId=927221060540c, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db822206100, createdName=double⭕, createdTime=Wed Dec 14 19:55:01 CST 2022, time=2022-12-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247437, encodeId=4640124e437ad, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d85710310, createdName=ms2000000623101699, createdTime=Tue Sep 06 11:00:11 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052999, encodeId=c4831052999be, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Sep 19 11:43:08 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013032, encodeId=2743101303270, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 23:43:18 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009200, encodeId=77ba10092007f, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Wed Aug 18 18:15:42 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-08-18 gujun830412

    想学习

    0

拓展阅读

2010 GOLD 慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2010-01-01

2010JRS 日本呼吸学会慢性阻塞性肺疾病(COPD)诊治指南(概述)

日本呼吸学会(JRS,the Japanese Respiratory Society) · 2010-02-01

2011 GOLD 慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2011-12-01

2013 GOLD 慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略(修订版)

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2013-02-13

2013 西班牙COPD指南:慢性阻塞性肺疾病基于临床表型的分级和治疗

西班牙肺病和胸外科学会(SEPAR,Spanish Society of Pneumology and Thoracic Surgery) · 2013-03-20